Several lines of evidence have supported a link between LDLR and carcinomas, demonstrating the increase in LDLR activity during the growth phase and decrease in quiescent cells in a number of carcinoma cell lines [23,24] and tumor growth suppression in LDLR-deficient mice [25]. The gene discussed is LDLR; the disease is neoplasm.